NO995808L - Forbindelser, deres fremstilling og anvendelse for overfoering av nukleinsyrer inn i celler - Google Patents

Forbindelser, deres fremstilling og anvendelse for overfoering av nukleinsyrer inn i celler

Info

Publication number
NO995808L
NO995808L NO995808A NO995808A NO995808L NO 995808 L NO995808 L NO 995808L NO 995808 A NO995808 A NO 995808A NO 995808 A NO995808 A NO 995808A NO 995808 L NO995808 L NO 995808L
Authority
NO
Norway
Prior art keywords
compounds
nucleic acids
cells
transfer
preparation
Prior art date
Application number
NO995808A
Other languages
English (en)
Other versions
NO995808D0 (no
NO314497B1 (no
Inventor
Gerardo Byk
Cathrine Dubertret
Daniel Scherman
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO995808D0 publication Critical patent/NO995808D0/no
Publication of NO995808L publication Critical patent/NO995808L/no
Publication of NO314497B1 publication Critical patent/NO314497B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
NO19995808A 1997-05-28 1999-11-26 Lipopolyamin i D-, L- eller DL-form, deres fremstilling og anvendelse samtpreparater inneholdende forbindelsene NO314497B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706549A FR2763943B1 (fr) 1997-05-28 1997-05-28 Composes, leur preparation et leur utilisation pour le transfert d'acides nucleiques dans les cellules
PCT/FR1998/001041 WO1998054130A1 (fr) 1997-05-28 1998-05-25 Composes, leur preparation et leur utilisation pour le transfert d'acides nucleiques dans les cellules

Publications (3)

Publication Number Publication Date
NO995808D0 NO995808D0 (no) 1999-11-26
NO995808L true NO995808L (no) 1999-11-26
NO314497B1 NO314497B1 (no) 2003-03-31

Family

ID=9507333

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995808A NO314497B1 (no) 1997-05-28 1999-11-26 Lipopolyamin i D-, L- eller DL-form, deres fremstilling og anvendelse samtpreparater inneholdende forbindelsene

Country Status (17)

Country Link
US (1) US6300321B1 (no)
EP (1) EP0984925B1 (no)
JP (1) JP4467084B2 (no)
KR (1) KR20010013029A (no)
CN (1) CN1131208C (no)
AT (1) ATE284383T1 (no)
AU (1) AU738320B2 (no)
BR (1) BR9809506A (no)
CA (1) CA2290664C (no)
DE (1) DE69828045T2 (no)
FR (1) FR2763943B1 (no)
HU (1) HUP0001937A3 (no)
IL (1) IL132951A0 (no)
NO (1) NO314497B1 (no)
PL (1) PL336983A1 (no)
WO (1) WO1998054130A1 (no)
ZA (1) ZA984440B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7314926B1 (en) 1999-04-08 2008-01-01 Antisoma Research Limited Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin
US8114850B2 (en) 1999-04-08 2012-02-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US7960540B2 (en) 1999-04-08 2011-06-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US20020091242A1 (en) 2000-10-11 2002-07-11 Michel Bessodes Acid-sensitive compounds, their preparation and uses
WO2002043769A2 (en) * 2000-11-29 2002-06-06 Gencell S.A. Neutral and anionic colloidal particles for gene delivery
US20030134423A1 (en) * 2002-01-04 2003-07-17 Chu Yong Liang Compounds for delivering substances into cells
WO2003106636A2 (en) * 2002-06-14 2003-12-24 Mirus Corporation Novel methods for the delivery of polynucleotides to cells
US7906122B2 (en) * 2003-06-18 2011-03-15 Yissum Research Development Company Of The Hebrew University Of Jersusalem Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination
BRPI0411505A (pt) * 2003-06-18 2006-07-25 Yissum Res Dev Co uso de um composto, método para modular a resposta imune de um indivìduo, composição farmacêutica, vacina, complexo, e, kit para a captura de uma molécula biologicamente ativa
GB0413613D0 (en) * 2004-06-17 2004-07-21 Univ London Small molecule carriers
KR100699279B1 (ko) 2005-04-28 2007-03-23 학교법인 포항공과대학교 당 또는 당 유사체를 골격으로 하는 분자 수송체 및 그의제조방법
US7973084B2 (en) 2005-04-28 2011-07-05 Postech Academy-Industrial Foundation Molecular transporters based on alditol or inositol and processes for the preparation thereof
JP5484728B2 (ja) * 2005-08-10 2014-05-07 ジョンズ ホプキンス ユニバーシティ 抗寄生虫治療薬および抗癌治療薬ならびにリジン特異的デメチラーゼ阻害物質として有用なポリアミン類
GB0613753D0 (en) * 2006-07-11 2006-08-23 Norwegian Radium Hospital Res Method
DE21212055T1 (de) 2011-12-07 2022-08-04 Alnylam Pharmaceuticals, Inc. Biologisch abbaubare lipide zur freisetzung von wirkstoffen
HUE060907T2 (hu) 2014-06-25 2023-04-28 Acuitas Therapeutics Inc Új lipidek és lipid nanorészecske formulációk nukleinsavak bevitelére
IL283545B2 (en) 2015-06-29 2023-09-01 Acuitas Therapeutics Inc Lipids and nanoparticulate lipid formulations for delivery of nucleic acids
PT3368507T (pt) 2015-10-28 2023-02-07 Acuitas Therapeutics Inc Novos lípidos e formulações de nanopartículas lipídicas para distribuição de ácidos nucleicos
US11357856B2 (en) 2017-04-13 2022-06-14 Acuitas Therapeutics, Inc. Lipids for delivery of active agents
EP3615510B1 (en) 2017-04-28 2024-03-27 Acuitas Therapeutics, Inc. Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
WO2019036008A1 (en) 2017-08-16 2019-02-21 Acuitas Therapeutics, Inc. LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS
US11542225B2 (en) 2017-08-17 2023-01-03 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
US11524932B2 (en) 2017-08-17 2022-12-13 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
BR112021013654A2 (pt) 2019-01-11 2021-09-14 Acuitas Therapeutics, Inc. Lipídeos para liberação de nanopartículas lipídicas de agentes ativos
CN116096702A (zh) 2020-07-16 2023-05-09 爱康泰生治疗公司 用于脂质纳米颗粒的阳离子脂质

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176715A1 (en) * 1993-11-24 1995-06-01 Timothy D. Heath Amphiphilic derivatives of guanidine
US5777153A (en) * 1994-07-08 1998-07-07 Gilead Sciences, Inc. Cationic lipids
FR2727679B1 (fr) * 1994-12-05 1997-01-03 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
FR2730637B1 (fr) * 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
FR2741066B1 (fr) * 1995-11-14 1997-12-12 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
ES2154453T3 (es) * 1996-03-01 2001-04-01 Centre Nat Rech Scient Compuestos pertenecientes a la familia de los amidiniums, composiciones farmaceuticas que les contienen y sus aplicaciones.

Also Published As

Publication number Publication date
EP0984925A1 (fr) 2000-03-15
JP4467084B2 (ja) 2010-05-26
HUP0001937A3 (en) 2003-10-28
CA2290664C (fr) 2010-04-13
AU8022198A (en) 1998-12-30
DE69828045T2 (de) 2005-12-01
ZA984440B (en) 1998-12-10
NO995808D0 (no) 1999-11-26
PL336983A1 (en) 2000-07-31
JP2002502388A (ja) 2002-01-22
US6300321B1 (en) 2001-10-09
EP0984925B1 (fr) 2004-12-08
WO1998054130A1 (fr) 1998-12-03
CN1131208C (zh) 2003-12-17
BR9809506A (pt) 2000-06-20
FR2763943A1 (fr) 1998-12-04
ATE284383T1 (de) 2004-12-15
CA2290664A1 (fr) 1998-12-03
CN1257480A (zh) 2000-06-21
HUP0001937A2 (hu) 2000-10-28
KR20010013029A (ko) 2001-02-26
FR2763943B1 (fr) 1999-07-09
NO314497B1 (no) 2003-03-31
IL132951A0 (en) 2001-03-19
AU738320B2 (en) 2001-09-13
DE69828045D1 (de) 2005-01-13

Similar Documents

Publication Publication Date Title
NO995808D0 (no) Forbindelser, deres fremstilling og anvendelse for overföring av nukleinsyrer inn i celler
CY1119742T1 (el) Βιολογικα συστηματα μεταφορας πολλαπλου-συστατικου
NO962791D0 (no) Preparater inneholdende nukleinsyrer, deres fremstilling og anvendelse
MXPA03001511A (es) Imidazol-5-il-2-amino-pirimidinas como agentes para la inhibicion de la proliferacion celular.
HK1044545A1 (zh) 貝他分泌酶組合物及其方法
DK1148875T3 (da) Fremgangsmåder og sammensætninger til forögelse af antallet af hvide blodlegemer
CL2008000057A1 (es) Composicion que comprende una enzima capaz de escindir un enlace para liberar una proteina o un carbohidrato de la superficie celular; uso de dicha enzima para tratar o aliviar el riesgo de una infeccion del tracto digestivo.
DE60003347D1 (de) Kraftstoffübertragungssystem
PT1169460E (pt) Preparacao de moleculas biologicamente activas.
IL149942A0 (en) Cellular compositions capable of long term culture, methods for preparing the same and modified animals derived therefrom
GB9930519D0 (en) Uses of transport proteins
IL143983A0 (en) Use of cellular transport systems for the transfer of nucleic acids through the nuclear envelope
NO20022022L (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
IT1317478B1 (it) Procedimento per la manipolazione e il trasferimento di forme per ilmontaggio di calzature.
MXPA02002838A (es) Derivados de piperazina sustituidos, su obtencion y uso como medicamentos.
IL137247A0 (en) Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
PT1165031E (pt) Composicao do resorcinol
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
IT1313660B1 (it) Procedimento stereoselettivo per la preparazione di endo-3-amminoazabicicloalcani.
WO2002028874A3 (en) Tumor proliferation inhibitors
DE60033943D1 (de) Schwefelfreie enzyme
NO20021634D0 (no) Fremstilling av rekombinante adenoviruser og adenovirusbanker
HUP0200345A2 (hu) Új nukleinsav-transzferáló ágensek, ezeket tartalmazó készítmények és alkalmazásuk
AR026890A1 (es) Composiciones de tenocitos, preparaciones y utilizaciones
ITTO910697A1 (it) Enzima immobilizzato, relativo procedimento di preparazione ed impiego